Product Image

Ginkgo

Herb Pharm
4.6
★ ★ ★ ★ ★
(192 ratings)
Ginkgo
Product Image
Score61
A high-weight liquid ginkgo extract with flexible dosing but little potency context. Missing standardization makes the large amount less reassuring than it appears.
How scoring works
Quantity:1 Liquid(s) • (42 servings)
Goals:
Cognitive Support
Brain Health
Productivity Boost
Mental Focus

Score 61

A high-weight liquid ginkgo extract with flexible dosing but little potency context. Missing standardization makes the large amount less reassuring than it appears.
How scoring works
$12.69($0.30 per serving)
Pure Formulas
$ 15.18
Vitacost
$ 12.69
iHerb
$ 16.77
Report prices

Analysis

The dropper serving supplies 660 mg of ginkgo leaf extract, an unusually large amount by weight. No flavone-glycoside, terpene-lactone, or ginkgolic-acid specifications show how much standardized active material it contains.

Ginkgo may support cerebral circulation and selected aspects of memory. Evidence depends heavily on extract quality, and the high weight does not guarantee better focus, productivity, or vision outcomes.

The liquid fits users who need flexible dosing or cannot take capsules. People seeking predictable potency should favor a standardized extract at a better-established amount.

Who is it for
  • Adults who prefer liquid botanicals
  • People who need adjustable servings
  • Users focused on circulation-related cognition
Best for
  • Capsule-free ginkgo use
  • Flexible dropper routines
  • General botanical supplementation

Pros

  • Clearly states the extract weight
  • Flexible liquid format
  • Single-botanical formula

Cons

  • No active-marker standardization
  • Unusually large amount lacks clear added benefit
  • No ginkgolic-acid purity limit

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.
  • Accurate dropper measurement matters because the supplied serving is already large.
  • Headache, dizziness, or digestive upset may occur.

Nutrient quality

52 Moderate impact

The extract amount is clear, but active-marker standardization and purity are not verified. The formula supplies an unnecessarily large extract amount without verified active yield, with a meaningful dose or safety limitation.

.

Ingredient transparency

77 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

62 Moderate impact

The supplied average is positive but less compelling and the response volume is limited. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

47 Lower impact

Low cost alone does not establish value when active yield or appropriate dosing is uncertain. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Cognitive Support
Cognitive Support
Impact
High effect
B Goal FitB Strength of SupportF CoverageA Formula Quality

Ginkgo may support cerebral blood flow and selected aspects of memory, giving it a direct cognitive mechanism. The 660 mg extract amount is disclosed, but no active-marker standardization is shown.

Evidence is mixed for cognitive enhancement in healthy adults and is more relevant to age-related decline or circulation-related needs. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Study evidence
Ginkgo Supportive 87 studies
Brain Health
Brain Health
Impact
High effect
B Goal FitD+ Strength of SupportD- CoverageA Formula Quality

Ginkgo directly targets cerebral circulation and has relevant human evidence for cognitive support. The large liquid amount is difficult to interpret without active-marker standardization.

The liquid extract is not standardized to active markers and provides more material than established benefit requires. Ginkgo may raise bleeding risk with anticoagulant or antiplatelet drugs, so concurrent use needs specific medical review.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Productivity Boost
Impact
Moderate effect
C Goal FitD- Strength of SupportF CoverageB+ Formula Quality

Ginkgo extract may support circulation and selected aspects of memory, but evidence for acute productivity in healthy adults is inconsistent. The very large extract amount does not compensate for missing active-marker standardization.

A liquid serving allows flexible use, yet ginkgoflavone, terpene-lactone, and ginkgolic-acid specifications are absent. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Mental Focus
Mental Focus
Impact
Moderate effect
C+ Goal FitF Strength of SupportF CoverageA Formula Quality

Ginkgo may support focus through cerebral circulation and related cognitive mechanisms. Human evidence is mixed and depends heavily on using a well-standardized extract.

The 660 mg extract is unusually high, while no active-marker percentages or ginkgolic acid limit are supplied. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Ginkgo leaf (Ginkgo biloba) extract
660 mg
Gluten Free Adults 18–50 Organic
Report overview
Ginkgo · 660 mg OverallScore23
F Active Ingredient Quality & BioavailabilityD+ Dose, Safety & Label TransparencyF Value

The liquid provides a large extract amount but gives no active-marker standardization or ginkgolic-acid purity information. Its dose exceeds the range supported for added benefit, which weakens otherwise moderate cost efficiency. Ginkgo may raise bleeding risk with anticoagulants or antiplatelet drugs, so concurrent use requires specific medical review.

View ingredientView products
Loading alternative details
83 Performance

Ginkgold 120 mg

Nature's Way
A 120 mg Ginkgold extract identified by flavone glycosides and terpene lactones offers a focused, substantial ginkgo dose. Exact marker percentages and a ginkgolic-acid limit are not supplied, so extract characterization is still incomplete.
84 Performance

Ginkgo Biloba Phytosome 60 mg

Natural Factors HerbalFactors
A 60 mg Ginkgoselect phytosome uses a distinct delivery format that may suit someone prioritizing a compact dose. The supplied label does not state flavone, terpene, or ginkgolic-acid details, which limits direct potency comparison.
84 Performance

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A concise 120 mg extract identified by flavone glycosides and terpene lactones provides stronger dose depth than many 40 mg or 60 mg formulas. Marker percentages and a ginkgolic-acid limit are not shown, but the simple formula supports clear comparison.
83 Budget

Ginkgo Biloba 60 mg

NOW
A lower recurring cost provides a 60 mg extract identified by ginkgo flavone glycosides and terpene lactones plus 200 mg of ginkgo powder. Marker percentages are not stated, but the added powder and long supply provide useful depth for the cost.
84 Budget

Ginkgo Biloba Certified Extract 120 mg

Life Extension
A lower recurring cost provides 120 mg of ginkgo with flavone glycosides, terpene lactones, and a stated low ginkgolic-acid limit. Exact marker percentages are not shown, while the impurity limit and long supply improve practical quality.
83 Budget

Ginkgo Biloba 60 mg

Swanson Superior Herbs
A lower recurring cost provides a branded 60 mg GinkgoSelect extract identified by flavone glycosides and terpene lactones. The marker percentages are missing, but the focused formula remains easy to assess and inexpensive to use.
84 Value

Ginkgo Biloba 120 mg

California Gold Nutrition EuroHerbs
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones combines a substantial dose with a long supply. The missing marker percentages and ginkgolic-acid limit are the main quality gaps.
80 Value

Double Strength Ginkgo Biloba 120 mg

NOW
A lower serving cost than the original accompanies the following trade-off: a 120 mg ginkgo extract identified by flavone glycosides and terpene lactones is paired with 250 mg of eleuthero at a low serving cost. Exact ginkgo marker percentages are absent, and eleuthero makes the formula less focused than a single-ingredient option.
80 Value

Ginkgo-24 120 mg

Source Naturals
A lower serving cost than the original accompanies the following trade-off: a simple 120 mg ginkgo extract identifies both flavone glycosides and terpene lactones at a moderate serving cost. The label does not state exact marker percentages or a ginkgolic-acid limit.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledProductivity Boost Brain Health forGinkgo
  8. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  9. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  10. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  11. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  12. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  13. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  18. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  19. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  20. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  21. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  22. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  23. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  24. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  25. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  26. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  27. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  28. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo